Primary Aldosteronism

W. Reid Litchfield1, Robert G. Dluhy1
1From the Endocrine-Hypertension Division, Brigham and Women′s Hospital and Harvard Medical School, Boston, Massachusetts

Tài liệu tham khảo

Arteaga, 1985, Use of the saline infusion test to diagnose the cause of primary aldosteronism, Am J Med, 79, 722, 10.1016/0002-9343(85)90523-6 Banks, 1984, Primary adrenal hyperplasia: A new subset of primary aldosteronism, J Clin Endocrinol Metab, 58, 783, 10.1210/jcem-58-5-783 Biglieri, 1989, Identification and implications of key types of mineralo-corticoid hypertension, J Steroid Biochem, 32, 199, 10.1016/0022-4731(89)90164-7 Biglieri, 1979, Effect of posture on the plasma concentration of aldosterone in hypertension and primary hyperaldosteronism, Nephron, 23, 112, 10.1159/000181618 Blumenfeld, 1994, Diagnosis and treatment of primary hyperaldosteronism, Ann Intern Med, 121, 877, 10.7326/0003-4819-121-11-199412010-00010 Bravo, 1983, The changing clinical spectrum of primary aldosteronism, Am J Med, 74, 641, 10.1016/0002-9343(83)91022-7 Bravo, 1986, Calcium channel blockade with nifedipine in primary aldosteronism, Hypertension, 8, 191 Bravo, 1994, Primary aldosteronism: Issues in diagnosis and management, Endocrinol Clin North Am, 23, 271, 10.1016/S0889-8529(18)30097-5 Bravo, 1993, Primary aldosteronism: New approaches to diagnosis and management, Cleve Clin J Med, 60, 379, 10.3949/ccjm.60.5.379 Bursztyn, 1988, The absence of long-term therapeutic effect of calcium channel blockade in the primary aldosteronism of adrenal adenomas, Am J Hypertens, 1, 88S, 10.1093/ajh/1.3.88S Campbell, 1992, Fibrosis of the human heart and systemic organs in adrenal adenoma, Blood Press, 1, 149, 10.3109/08037059209077510 Campbell, 1993, Myocardial fibrosis in the rat with mineralocorticoid excess: Prevention of scarring by amiloride, Am J Hypertens, 6, 487, 10.1093/ajh/6.6.487 Campbell, 1992, Fibrosis of the human heart and other organs in adrenal adenoma, Blood Pressure, 1, 149, 10.3109/08037059209077510 Carey, 1984, Idiopathic hyperaldosteronism: A possible role for aldosterone-stimulating factor, N Engl J Med, 311, 94, 10.1056/NEJM198407123110205 Carey, 1986, Recent progress in the control of aldosterone secretion, Recent Prog Horm Res, 42, 251 Chu, 1982, Isolation and identification of 18-hydroxycortisol from the urine of patients with primary aldosteronism, J Biol Chem, 258, 2218, 10.1016/S0021-9258(18)34909-3 Conn, 1955, Presidential address: Part I. Painting background: II. Primary aldosteronism, a new clinical syndrome, J Lab Clin Med, 45, 3 Copeland, 1983, The incidentally discovered adrenal mass, Ann Intern Med, 98, 940, 10.7326/0003-4819-98-6-940 Dluhy, 1994, Glucocorticoid-remediable aldosteronism, Endocrinol Clin North Am, 23, 285, 10.1016/S0889-8529(18)30098-7 Doppman, 1992, Distribution between hyperaldosteronism due to bilateral hyperplasia and unilateral aldosteronoma: Reliability of CT, Radiology, 184, 677, 10.1148/radiology.184.3.1509049 Dunnick, 1993, CT in the diagnosis of primary aldosteronism: Similarity in 29 patients, Am J Roentgenol, 160, 321, 10.2214/ajr.160.2.8424342 Fontes, 1991, Reassessment of the predictive value of the postural stimulation test in primary aldosteronism, Am J Hypertens, 4, 786, 10.1093/ajh/4.9.786 Fraser, 1978, 18-Hydroxcorticosterone: A review, J Steroid Biochem, 9, 273, 10.1016/0022-4731(78)90161-9 Freed, 1991, Effects of calcium channel blockers on potassium homeostasis, Yale J Biol Med, 64, 177 Ganguly, 1973, Anomalous postural response of plasma aldosterone concentration in patients with aldosterone-producing adrenal adenoma, J Clin Endocrinol Metab, 36, 401, 10.1210/jcem-36-2-401 Ganguly, 1992, Cellular origin of aldosteronomas, Clin Invest, 70, 392, 10.1007/BF00235519 Ganguly, 1973, Control of plasma aldosterone in primary aldosteronism: Distinction between adenoma and hyperplasia, J Clin Enocrinol Metab, 37, 765, 10.1210/jcem-37-5-765 Ganguly, 1983, Primary aldosteronism: Pathophysiology, diagnosis and treatment, J Urol, 129, 241, 10.1016/S0022-5347(17)52033-9 Gomez-Sanchez, 1985, Receptor binding and biological activity of 18-oxo-cortisol, Endocrinology, 116, 6, 10.1210/endo-116-1-6 Gomez-Sanchez, 1984, Elevated urinary excretion of 18-oxocortisol in glucocorticoid supressible aldosteronism, J Clin Endocrinol Metab, 59, 1022, 10.1210/jcem-59-5-1022 Gregoire, 1994, Adjustment of the osmostat in primary aldosteronism, Mayo Clin Proc, 69, 1108, 10.1016/S0025-6196(12)61380-9 Hambling, 1992, Re-evaluation of the captopril test for the diagnosis of primary hyperaldosteronism, Clin Endocrinol (Oxf), 36, 499, 10.1111/j.1365-2265.1992.tb02252.x Hiramatsu, 1981, A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity: Results in hypertensive patients, Arch Intern Med, 141, 1589, 10.1001/archinte.1981.00340130033011 Holland, 1984, Further evaluation of saline infusion for the diagnosis of primary aldosteronism, Hypertension, 6, 717, 10.1161/01.HYP.6.5.717 Honda, 1984, A simplified screening test for differentiating primary aldosteronism from essential hypertension with low plasma renin activity, Jpn Circ J, 44, 719, 10.1253/jcj.44.719 Hsueth, 1986, New insights into the medical management of primary aldosteronism, Hypertension, 8, 76, 10.1161/01.HYP.8.1.76 1990, Hypokalemia, aldosteronism, and renal cysts [letter], N Engl J Med, 323, 29 Ikeda, 1989, The detection of adrenal tumors and hyperplasia in patients with primary aldosteronism: Comparison of scintigraphy, CT and MR imaging, Am I Roentgenol, 153, 301, 10.2214/ajr.153.2.301 Irony, 1990, Correctable subsets of primary aldosteronism: Primary adrenal hyperplasia and renin responsive adenoma, Am I Hypertens, 3, 576, 10.1093/ajh/3.7.576 Kem, 1971, Saline suppression of plasma aldosterone in hypertension, Arch Intern Med, 128, 380, 10.1001/archinte.1971.00310210056004 Laidlaw JC: Dexamethasone-suppressible hyperaldosteronism: Patients JS and LS 20 years later. In New MI, Borrelli P (eds): Dexamethasone-suppressible Hyperaldosteronism. Serono Symposia Review no. 10, Rome, 1986, pp 133-137 Lieberman, 1994, Pediatric hypertension: Clinical perspective, Mayo Clin Proc, 69, 1098, 10.1016/S0025-6196(12)61379-2 Lifton, 1992, A chimaeric 11-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension, Nature, 355, 262, 10.1038/355262a0 Lifton, 1992, Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase, Nature Genet, 2, 66, 10.1038/ng0992-66 Lins, 1986, Plasma aldosterone-plasma renin activity ratio: A simple test to identify patients with primary aldosteronism, Acta Endocrinol, 113, 564, 10.1530/acta.0.1130564 Lyons, 1983, Single dose captopril as a diagnostic test for primary aldosteronism, J Clin Endocrinol Metab, 57, 892, 10.1210/jcem-57-5-892 McKenna, 1991, Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism, J Clin Endocrinol Metab, 73, 952, 10.1210/jcem-73-5-952 Melby, 1991, Diagnosis of hyperaldosteronism, Endocrinol Clin North Am, 20, 247, 10.1016/S0889-8529(18)30266-4 Morgenstern, 1994, Hypertension in pediatric patients: Current issues, Mayo Clin Proc, 69, 1089, 10.1016/S0025-6196(12)61378-0 Muratani, 1987, Single oral administration of captopril may not bring an improvement in screening for primary aldosteronism, Clin Exp Hypertens, A9, 611 Nadler, 1985, Therapeutic effect of calcium channel blockade in primary aldosteronism, J Clin Endocrinol Metab, 60, 896, 10.1210/jcem-60-5-896 Naomi, 1987, Effects of sodium intake on the captopril test for primary aldosteronism, Jpn Heart J, 28, 357, 10.1536/ihj.28.357 Naomi, 1985, Clinical evaluation of the captopril screening test for primary aldosteronism, Jpn Heart J, 26, 549, 10.1536/ihj.26.549 Neville, 1985, Histopathology of the human adrenal cortex, Clin Endocrinol Metab, 14, 791, 10.1016/S0300-595X(85)80078-5 New, 1967, A new form of congenital adrenal hyperplasia, J Clin Endocrinol Metab, 27, 300, 10.1210/jcem-27-2-300 Noth, 1988, Primary hyperaldosteronism, Med Clin North Am, 72, 1117, 10.1016/S0025-7125(16)30732-5 Opocher, 1993, Differential diagnosis in primary aldosteronism, J Steroid Biochem Molec Biol, 45, 49, 10.1016/0960-0760(93)90121-C Osella, 1994, Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas), J Clin Endocrinol Metab, 79, 1532, 10.1210/jcem.79.6.7989452 Priestley, 1968, Primary aldosteronism: Surgical management and pathological findings, Mayo Clinic Proc, 48, 761 Reznek, 1994, Imaging in endocrinology: The adrenal gland, Clin Endocrinol, 40, 561, 10.1111/j.1365-2265.1994.tb03006.x Rich, 1992, Glucocorticoid-remediable aldosteronism in a large kindred: Clinical spectrum and diagnosis using a characteristic biochemical phenotype, Ann Intern Med, 116, 813, 10.7326/0003-4819-116-10-813 Schambelan, 1976, Circadian rhythm and effect of posture on plasma aldosterone concentration in primary aldosteronism, J Clin Endocrinol Metab, 43, 115, 10.1210/jcem-43-1-115 Sen, 1981, Localization, purification, and biological activity of a new aldosterone-stimulating factor, Hypertension, 3, 181, 10.1161/01.HYP.3.3_Pt_2.I81 Stimpel, 1988, Are calcium antagonists helpful in the management of primary aldosteronism?, J Cardiovasc Pharmacol, 12, S131, 10.1097/00005344-198812006-00033 Streeten, 1979, Reliability of screening methods for the diagnosis of primary aldosteronism, Am J Med, 67, 403, 10.1016/0002-9343(79)90786-1 Sun, 1993, Angiotensin converting enzyme and myocardial fibrosis in the rat receiving angiotensin II and aldosterone, J Lab Clin Med, 122, 395 Sutherland, 1966, Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone, Can Med Assoc I, 95, 1109 Torres, 1990, Association of hypokalemia, hypoaldosteron-ism, and renal cysts, N Engl J Med, 322, 345, 10.1056/NEJM199002083220601 Ulick, 1993, The unique steroidogenesis of the aldostero-noma in the differential diagnosis of primary aldosteronism, J Clin Endocrinol Metab, 76, 873 Ulick, 1983, Biosynthesis of 18-oxocortisol by aldosterone producing adrenal tissue, J Biol Chem, 258, 5498, 10.1016/S0021-9258(20)81918-8 Weinberger, 1979, Primary aldosteronism: Diagnosis, localization and treatment, Ann Intern Med, 90, 386, 10.7326/0003-4819-90-3-386 Weinberger, 1984, Primary aldosteronism: Diagnosis and differentiation of subtypes, Ann Intern Med, 100, 300, 10.7326/0003-4819-100-2-300 Williams, 1972, Studies of the control of plasma aldosterone concentration in normal man: I. Response to posture, acute and chronic volume depletion, and sodium loading, J Clin Invest, 51, 1731, 10.1172/JCI106974 Wisgerhof, 1981, The plasma aldosterone response to angiotensin II infusion in aldosterone-producing adenoma and idiopathic hyperaldosteronism, J Clin Endocrinol Metab, 52, 195, 10.1210/jcem-52-2-195 Yamakita, 1994, Plasma 18-oxocortisol levels in the patients with adrenocortical disorders, Clin Endocrinol (Oxf), 40, 583, 10.1111/j.1365-2265.1994.tb03008.x Young, 1988, Primary aldosteronism: Diagnostic evaluation, Endocrinol Metab Clin North Am, 17, 367, 10.1016/S0889-8529(18)30425-0 Young, 1990, Primary aldosteronism: Diagnosis and treatment, Mayo Clin Proc, 65, 96, 10.1016/S0025-6196(12)62114-4